Dengue is the major Arbovirus in the world, annually causing morbidity and death. Severe dengue is associated with changes in the endothelial barrier function due to the production of inflammatory mediators by immune cells and by the endothelium. Dengue virus (DENV) replicates efficiently in human endothelial cells in vitro and elicits immune responses resulting in endothelial permeability. Uncaria tomentosa (Willd.) DC.(Rubiaceae), known as cat's claw, has been used in folk medicine for the treatment of a wide-array of symptoms, and several scientific studies reported its antiviral, immunomodulatory, anti-inflammatory and antioxidant properties. Here we infected a human lineage of dermal microvascular endothelial cells (HMEC-1) with DENV-2 and treated it with an alkaloidal fraction from U. tomentosa bark (AFUT). We showed antiviral and immunomodulatory activities of U. tomentosa by determining the NS1 antigen and IL-8 in supernatant of DENV-2 infected HMEC-1. Furthermore, by measurement of transendothelial electrical resistance (TEER) we demonstrated, for the first time, that a plant derivative contributed to the reduction of paracellular permeability in DENV-2 infected HMEC-1. We also showed that IL-8 contributed significantly to the induction of permeability. Although further investigations should be conducted before a new drug can be suggested, our in vitro data support evidence that AFUT could be potentially useful in developing a treatment for severe dengue.
Dengue is the most important mosquito-borne viral disease of the world causing, annually, enormous death numbers as well as significant economic losses [1] . The dengue virus (DENV) has 4 serotypes (1) (2) (3) (4) and infection by any one of them can result in a wide spectrum of clinical manifestations that can be classified according to the severity level. Severe dengue is characterized by plasma leakage that may lead to shock, besides organ impairment and occasionally severe hemorrhages [2] .
The endothelium is the primary barrier of the circulatory system and plays an important role in regulating vessel permeability and maintaining hemostasis. During certain diseases, such as dengue, the endothelial cell (EC) function can be changed leading to plasma leakage. DENV infected ECs may contribute directly to pathogenesis by increasing viremia, secreting cytokines, modulating complement pathways, or transforming the endothelium into an immunologic target of cellular and humoral immune responses [3] . During innate immune responses against dengue, factors such as MCP-1, MMP, MIF, and TNF-α play an important role in endothelial cell activation being detected at increased circulating levels in severe patients [3, 4] . Interleukin-8 (IL-8) is among the main factors that contribute to endothelial permeability [5] .
Currently, patients are treated only symptomatically, since there is neither an effective approved vaccine for use nor a specific therapeutic agent for dengue [6] . Natural products remain one of the most important sources for the development of new drugs, but their potential against DENV infection has not been well explored [7] . Uncaria tomentosa (Willd.) DC (Rubiaceae), known as "cat's claw", is a woody vine distributed from the Amazonian to Central American rain forest. This plant, commonly used in folk medicine, having antiviral, immunomodulatory, anti-inflammatory and antioxidant properties, has been scientifically studied [8] [9] [10] [11] [12] . For DENV-infected human monocytes, an aqueous-ethanol extract of U. tomentosa bark and its alkaloid enriched fraction presented inhibitory activities on virus load and cytokine production [12] . In the present work we further investigated the effect of this same alkaloidal fraction on human dermal microvascular endothelial cells in an in vitro infection model demonstrating its antiviral activity as well as the reduction of endothelial permeability.
The total pentacyclic oxindole alkaloid content in the crude aqueous-ethanol extract of U. tomentosa was calculated as 29.1 mg/g (± 1%). The HPLC analysis of this alkaloidal fraction (AFUT) revealed the six pentacyclic oxindole alkaloids (POA) that are currently considered the chemical markers of the species: speciophylline, mitraphylline, uncarine F, pteropodine, isomitraphylline and isopteropodine [12, 13] . All concentrations of AFUT used in the following experiments presented no cytotoxicity to HMEC-1 cell cultures according to the tetrazolium salt (MTT) reduction assay.
The antiviral activity was detected by the reduction of NS1 antigen secretion in DENV-2 infected HMEC-1 at 24 and 48 h postinfection (p.i.) at AFUT concentrations from 1-50 µg/mL ( Figure  1 ). The decrease in NS1 antigen was statistically significant when the infected HMEC-1 were treated with AFUT at either 1 (24 and 48 h p.i.) or 50 µg/mL (48 h p.i). As observed by Reis et al. [12] , who used DENV-2 infected monocytes, we also showed that AFUT at 1 µg/mL induced a significant antiviral effect in endothelial cells. cells. An immunomodulating effect was detected by the reduction of IL-8 production in supernatant from DENV-2 infected HMEC-1. Significant modulation of this cytokine was observed when infected HMEC-1 were treated with AFUT at either 1 (48 and 72 h p.i.) or 10 µg/mL (48 h p.i.). As observed for the detection of NS1 antigen, AFUT at 1 µg/mL revealed the most effective inhibitory activity ( Figure 2 ). IL-8 has been found in patients with severe dengue and is produced by endothelial cells infected in vitro with DENV [14, 15] . Recombinant IL-8 induced paracellular endothelial permeability in vitro as evaluated by albumin transendothelial migration assay [16, 17] , whereas recombinant TNF-α treatment evidenced permeability when transendothelial electrical resistance (TEER) assay was performed [18] .
In the present study we could definitely confirm IL-8 involvement in endothelial permeability using two different assays, TEER and streptavidin-HRP transendothelial migration ( Figure 3 ). Moreover, when supernatants from previously DENV-2 infected HMEC-1 were added to the EC monolayer, a more effective permeability induction was observed. Most probably a synergism between IL-8 and other molecules present in cell culture supernatant, such as IL-6 and RANTES [14, 19] , may be contributing to the further increase in permeability. The IL-8 role in changing the endothelium barrier function was confirmed when IL-8 neutralizing antibody was added to the permeability assays and partially recovered the TEER. Knowing that IL-8 and other cytokines play an important role in the modulation of the endothelium, much effort has been made to identify inhibitors of pro-inflammatory cytokine production [5] . Endothelial monolayer cultures provide an excellent model to study the endothelial barrier function and paracellular permeability in vitro [20] and the Endohm chamber enables reproducible and accurate measurements of the TEER [18] . We showed here that HMEC-1 infected with DENV-2 present a time-dependent increase in endothelial permeability that started after 24 h p.i. (Figure 4 ). The AFUT was added at 1 µg/mL immediately after viral adsorption and daily during 5 days. This treatment significantly reduced the endothelial permeability in the third and fourth days p.i. No significant effect was detected with single treatment, even at higher doses. Despite that, 1 µg/mL used once has shown significant reduction in the quantification of NS1 antigen and IL-8, and thus the permeability induction is a late event in cell cultures and also in the patient. It seems reasonable to treat cells continuously, avoiding the compounds remained long in culture, losing their effectiveness, and thus permitting virus replication and cytokine release to be reverted. Most antiviral and immunosuppressive drugs are administrated at multiple doses in vivo in order to be effective and justifying repeated treatment.
The endothelium is the primary fluid barrier of the vasculature and direct infection by DENV permits virus replication and induces immune-enhancing effects that increase vascular permeability and can result in severe dengue [3] . We confirmed here our previous results [12] on the in vitro antiviral and immunomodulatory activities of the alkaloidal fraction from U. tomentosa by applying a different experimental approach on studying endothelial cell line infection. We used here a simple method for detecting virus load that consists in the detection of a nonstructural protein -NS1.
Natural products have been able to reduce endothelial permeability induced by TNF-α and LPS [21, 22] . The data presented here show for the first time the role of a medicinal plant in attenuating endothelial permeability in vitro during DENV infection, as evidenced here with U. tomentosa treatment. DENV-2 infected endothelial cells increased permeability is a complex system that involves many factors; therefore, it would be unlikely to assign the IL-8 solely to effect the endothelium modulation [17, 18] . TNF-α, IL-8 and other factors, such as MCP-1, MMP and MIF, are likely to be acting synergistically and are all well known for their role in vascular permeability and shock [3] . U. tomentosa inhibited TNF-α production by regulating the NF-κB transcription factor [9] . NF-κB may regulate the expression of several other pro-inflammatory cytokines including IL-1, IL-2, IL-6 and IL-8 [23] .
It may be hypothesized that the immunomodulating activity may be a result of viral load reduction. Alternatively, induction of pathways that inhibit pro-inflammatory responses, such as NF-κB, and which stimulate antiviral mechanisms, such as interferons and nitric oxide production, may be occurring. For these reasons, further investigations are deserved in order to elucidate whether the effects observed in the present work are resulting from the drug action in the control of viral replication or acting on signaling pathways, or even an association of both. Surely, the future establishment of compounds acting on the vascular permeability during dengue may represent a great breakthrough in treating the severe clinical manifestations of this infection.
Experimental
Plant material: The alkaloidal fraction from the aqueous-ethanol 1:1 bark extract of Uncaria tomentosa (AFUT) employed in this study is the same as that used in previous studies [10, 12, 13, 24] . It resulted from acidifying (0.1 N HCl) the crude extract, followed by clean-up with ethyl acetate, treating the aqueous fraction with NH 4 OH until pH 9-10, and then partitioning with ethyl acetate [24] . The POA profile was determined by TLC using previously isolated standards [21] , and by HPLC-DAD-MS using a Lichrocart Lichrospher 5 µm, 125 × 4.6 mm i.d. column [12, 13] . The total POA content was determined by HPLC-UV through external standardization relative to isopteropodine [12] .
Cell culture: The human lineage of dermal microvascular endothelial cells (HMEC-1) was cultured in either EGM-2 MV complete medium (Lonza) or MCDB-131 medium (Sigma-Aldrich) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 10 ng/mL human epidermal growth factor, 1 µg/mL hydrocortisone, 2 mM L-glutamine, 100 µg/mL streptomycin and 100 U/mL penicillin.
Virus stock preparation and titration:
The DENV serotype 2 strain 16681was propagated as described before [12] . The supernatant containing the virus particles was ultracentrifuged (100,000 g) for 1 h at 4°C. The pellet was stored at -70ºC. Virus titer was calculated as 50% tissue culture infection dose (TCID 50 ) resulting in a concentration of 1.6 x 10 9 TCID 50 /mL.
Cell viability assay:
HMEC-1 were seeded in quadruplicate in a 96well tissue culture plate (BD Falcon) and incubated with AFUT at different concentrations (1, 10, 50 and 100 µg/mL) at 37ºC under 5% CO 2 for 2-5 days., The cytotoxicity effect of AFUT on the HMEC-1 was conducted using the Vybrant® MTT Cell Proliferation Assay (Molecular Probes), and the optical density was measured at 540-570 nm.
Antiviral effect by NS1 antigen determination:
HMEC-1 were seeded in 24-well plates in MCDB-131 medium and, after 2 days of growth at 37ºC under 5% CO 2 , infected with DENV-2 at a dilution of 1:10 for 2 h. Then, cells were washed, fresh medium (with 5% FBS) added and some wells containing infected cells were treated with different concentrations of AFUT (1, 10 and 50 µg/mL). After 24 h, 48 h and 72 h, supernatants were stored in aliquots at -70ºC. The Platelia Dengue NS1 AG kit (Bio-Rad) was used to quantify the DENV production in HMEC-1 cultures. Supernatants were diluted 1:10 and the assay was further performed according to manufacturer's instructions.
IL-8 determination by ELISA assay:
The IL-8 concentration was determined by employing the standard ELISA kit according to the manufacturer's instruction (PeproTech), using streptavidin-HRP (Zymed) and TMB solution (Invitrogen) as the substrate. The absorbance was read at 620 nm.
Endothelial permeability assay:
HMEC-1 were seeded (1.5 x 10 5 cells/insert) on fibronectin-coated (Sigma-Aldrich, 15 µg/mL), 24well, polyester membrane inserts (6.5 mm diameter, pore size 0.4 µm, Corning) with complete EGM-2 MV medium. Inserts were placed into lower chambers containing each 1100 µL of the same medium and incubated at 37ºC under 5% CO 2 . The paracellular permeability was measured using the Endohm chamber (WPI) connected to an electrical resistance system (Millicell-ERS, Millipore). Membrane inserts containing no cells were used for blank measurements. The TEER values were calculated using the following formula that considers the area of the insert membrane and the resistance value of the blank: (R exp -R b )*0.33 cm 2 . Once the monolayer was grown to confluence HMEC-1 were infected with DENV-2 inoculum (70 µL diluted 1:1 in medium) and incubated at 37ºC under 5% CO 2 for 2 h. Changed EGM-2 MV medium, contained 1 µg/mL of AFUT, in some inserts with infected cells (treated inserts). TEER measurements were performed every 24 h and then more AFUT (1µg/mL) was added. Uninfected cells were used as a control. The effect of IL-8 in the permeability was studied using basically the same procedures. Either recombinant IL-8 (4 ng/mL; PeproTech) or supernatant from DENV-2 infected HMEC-1 were either pre-incubated (overnight at 4ºC) or not with neutralizing antibody to IL-8 (6 µg/mL; PeproTech). After 6 h of incubation the TEER was measured and immediately the medium in both chambers was changed to RPMI without phenol red and streptavidin-HRP (3.13 µg/mL, Invitrogen) was added to the upper chamber. After 30 min aliquots (30 µL) from the lower chamber were assayed with TMB substrate and O.D. measured at 620 nm.
Statistical analysis:
For data that fitted into normal Gaussian distribution we used the paired t-test and for those that did not we used the Wilcoxon signed rank test. All statistical analyses were performed using the GraphPad Prism software.
